Sichuan Languang Development Co Ltd
SSE:600466
Intrinsic Value
Sichuan Languang Development Co., Ltd. engages in the development and operation of real estate. [ Read More ]
The intrinsic value of one
Sichuan Languang Development Co Ltd
stock under the Base Case scenario is
21.17
CNY.
Compared to the current market price of 0.4 CNY,
Sichuan Languang Development Co Ltd
is
Undervalued by 98%.
Sichuan Languang Development Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Sichuan Languang Development Co Ltd's market capitalization is 1.2B CNY.
Sichuan Languang Development Co Ltd stock price is 0.4 CNY.
Sichuan Languang Development Co Ltd stock price (0.4 CNY) is 98% less than its Intrinsic Value (21.17 CNY).
Sichuan Languang Development Co Ltd stock price (0.4 CNY) is 99% less than its DCF Value (36.16 CNY). Open DCF Valuation
Sichuan Languang Development Co Ltd stock price (0.4 CNY) is 94% less than its Relative Value (6.18 CNY). Open Relative Valuation
Sichuan Languang Development Co Ltd.
Sichuan Languang Development Co Ltd's Revenue has dropped by 18% over the past 12 months.
Sichuan Languang Development Co Ltd's long-term liabilties (153B CNY) exceed its long-term assets (128B CNY).
Sichuan Languang Development Co Ltd's short-term liabilties (141B CNY) exceed its short-term assets (116B CNY).
Sichuan Languang Development Co Ltd has negative Free Cash Flow for the last twelve months.
Sichuan Languang Development Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 2% to -18%.
Sichuan Languang Development Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from 16% to 216%.
Sichuan Languang Development Co Ltd has negative Gross Profit for the last twelve months.
Sichuan Languang Development Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -18%.
Sichuan Languang Development Co Ltd has negative Operating Income for the last twelve months.
Sichuan Languang Development Co Ltd has negative Net Income for the last twelve months.
Sichuan Languang Development Co Ltd's ROE (Return on Equity) for the past 12 months is very high and is equal to 216%.
Sichuan Languang Development Co Ltd has positive Net Debt. This means that the company has more debt (9B CNY) than cash and short-term investments (2B CNY).
Sichuan Languang Development Co Ltd has negative three-year average ROIC (Return on Invested Capital): -4%. The company is not efficient at using invested capital to generate operating income.
Sichuan Languang Development Co Ltd's Revenue has been falling by 24% per year for the last 3 years.
Sichuan Languang Development Co Ltd has very high three-year average ROE (Return on Equity): 117%. The company is very efficient at transforming stockholders' equity into net income.
Sichuan Languang Development Co Ltd's D/E (Debt to Equity) is very low and is equal to -0.35.
Sichuan Languang Development Co Ltd's Altman Z-Score is very low and is equal to -0.93.
Fundamental Analysis
Sichuan Languang Development Co Ltd
Balance Sheet Decomposition
Sichuan Languang Development Co Ltd
| Current Assets | 116.1B |
| Cash & Short-Term Investments | 2.4B |
| Receivables | 18.5B |
| Other Current Assets | 95.2B |
| Non-Current Assets | 12.4B |
| Long-Term Investments | 5.5B |
| PP&E | 2.5B |
| Intangibles | 327.3m |
| Other Non-Current Assets | 4B |
| Current Liabilities | 141.1B |
| Accounts Payable | 21.5B |
| Accrued Liabilities | 7.7B |
| Short-Term Debt | 2.9B |
| Other Current Liabilities | 109.1B |
| Non-Current Liabilities | 11.9B |
| Long-Term Debt | 5.7B |
| Other Non-Current Liabilities | 6.2B |
Earnings Waterfall
Sichuan Languang Development Co Ltd
|
Revenue
|
16.7B
CNY
|
|
Cost of Revenue
|
-16.8B
CNY
|
|
Gross Profit
|
-76.7m
CNY
|
|
Operating Expenses
|
-20.8B
CNY
|
|
Operating Income
|
-20.9B
CNY
|
|
Other Expenses
|
-4.4B
CNY
|
|
Net Income
|
-25.3B
CNY
|
Free Cash Flow Analysis
Sichuan Languang Development Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Sichuan Languang Development Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Sichuan Languang Development Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sichuan Languang Development Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Sichuan Languang Development Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sichuan Languang Development Co Ltd
Shareholder Return
Price
Sichuan Languang Development Co Ltd
| Average Annual Return | -25.58% |
| Standard Deviation of Annual Returns | 36.19% |
| Max Drawdown | -95% |
| Market Capitalization | 1.2B CNY |
| Shares Outstanding | 3 034 930 435 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Sichuan Languang Development Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Sichuan Languang Development Co., Ltd. engages in the development and operation of real estate. The company is headquartered in Chengdu, Sichuan and currently employs 2,791 full-time employees. The company went IPO on 2001-02-12. The Real Sstate Development & Operation segment has more than 100 development projects in nearly 20 cities in China. The Modern Service Industry segment provides property service based modern services through the subsidiary, Sichuan JUSTBON Asset Management Group Co., Ltd. The 3D Bio-printing segment is involved in the application of 3D bio-printing technology through the subsidiary, Sichuan Revotek Bio-technology Co., Ltd. The Medical segment is involved in the research and development, production and sales of medicine and medical instruments through the subsidiary, Chengdu Dikang Pharmaceutical Co., Ltd.
You don't have any saved screeners yet
